Clinical Trials Directory

Trials / Completed

CompletedNCT04420091

Hydrolyzed Fish Cartilage Effect on Knee Joint Functionality and Discomfort in Adult Population

Effect of Cartidyss-based Dietary Supplement on Knee Joint Functionality and Discomfort in Adult Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Abyss Ingredients · Industry
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study is an exploratory, non-comparative, multi-centric trial in 30 free-living healthy male and female subjects with moderate knee joint discomfort and loss of functionality. The objective of this trial is to determine whether oral administration of Cartidyss, a concentrated fish cartilage extract, can contribute to the improvement of knee joint functionality and discomfort in adult population

Detailed description

30 patients will be enrolled during a 4-month period in 3 investigational sites and each patient will undergo 3 visits (V0: Inclusion visit at baseline, V1: Follow-Up Visit after 1 month ± 3 day and V2: End Visit after 3 months ± 5 days). The primary objective of this trial is to determine whether oral administration of Cartidyss, a concentrated fish cartilage extract, can contribute to the improvement of knee joint functionality and discomfort in adult population, using a specific self-administered questionnaire. The secondary objectives of the study are to evaluate the effect of Cartidyss on knee function and pain at rest and while walking, with patient global assessment and quality of life at each time point. The tolerance, compliance, satisfaction, rate of responder to the supplementation and pain killer's consumption would be also evaluated as secondary endpoints.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCartidyssOral intake of two tablets of Cartidyss 500 mg, once daily in the morning, preferably during a meal, with water, during 3 months

Timeline

Start date
2020-06-11
Primary completion
2020-12-17
Completion
2020-12-17
First posted
2020-06-09
Last updated
2021-01-06

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04420091. Inclusion in this directory is not an endorsement.